-
Many clinical trials have confirmed the benefit of early invasive therapy for high-risk patients presenting with acute coronary syndromes (ACS). However, the optimal timing of cardiac catheterization in this group remains unknown.
-
Depression and pregnancy, new vaccine recommendations from the CDC, cortico-steroids and/or antivirals for Bell's palsy, rasagiline and Parkinson's disease, and FDA Actions.
-
-
Erratic intraindividual INR values on chronic warfarin therapy are thought to be due to variability in vitamin K intake in the diet. Thus, de Assis et al from Brazil hypothesized that a dietary, vitamin K management strategy would result in improved long-term anticoagulation as compared to traditional systems based upon drug-dose adjustments alone.
-
Dabigatran etexilate is an oral compound that is converted after absorption by a serum esterase to dabigatran, a direct competitive inhibitor of thrombin.
-
Current indications for cardiac-resynchronization therapy (CRT) require that patients have New York Heart Association (NYHA) Class III or Class IV heart-failure symptoms. However, long-standing ventricular dyssynchrony can lead to left-ventricular remodeling and decreased left-ventricular ejection fraction.
-
The timing of mitral valve surgery in patients with severe organic mitral regurgitation (MR), but without symptoms, is controversial.
-
PPIs and Clopidogrel: Do We Have to Worry?; Surgery vs Medical Treatment for CTS; Influenza Vaccine: Flu Shot vs Nasal Mist; Beleaguered Primary Care Clinicians; Beyond Diabetes Prevention; Does Metformin Affect Thyroid Function?
-
Concerns about the potential increased risk of prostate cancer associated with high intakes of alpha-linolenic acid (ALA; 18:3n-3) were re-assessed by the authors of this systematic review, but the aforementioned concerns could not be completely allayed.
-
There is no agreed upon standard therapy for men experiencing inflammatory chronic prostatitis/ chronic pelvic pain syndrome (CP/CPPS). The results of this strong clinical trial suggest that a 12-week course of therapy with a specific pollen extract is significantly more effective than placebo in reducing the symptoms of CP/CPPS, especially pain.